Ongoing Clinical Trials
Science of Silver™
TPT™ Pivotal Clinical Trials
Sienna is currently enrolling patients in pivotal clinical trials for our TPT™ therapy with SNA-001 for acne. If you are interested in learning more about participating in these pivotal clinical trials, please visit our clinical trial recruitment site at www.faceitstudy.com.
Topical by Design™ Phase 2 Clinical Trials
Sienna is currently enrolling patients in a Phase 2b clinical trial for our topical drug product candidate SNA-120 for psoriasis and associated pruritus. If you are interested in learning more about participating in this clinical trial, please visit our clinical trial recruitment site at www.psoriasisitch.com. Sienna is also enrolling patients in an exploratory Phase 2 clinical trial with SNA-120 in subjects treated with calcipotriene. Please click on the following links to learn more about the SNA-120 clinical trials at clinicaltrials.gov.
Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
Sienna is not currently providing access to any investigational therapies under an expanded access program. We encourage any person interested in gaining access to our potential medicines to consult their physician regarding the possibility of participating in one of our clinical trials.
Questions about our expanded access policy or information about our clinical trials may be submitted to ClinicalTrials@siennabio.com.
Science You Can See. Confidence You Can Feel.™